Targeting HER2 in the treatment of non-small cell lung cancer von Mar, Nataliya, Vredenburgh, James J, Wasser, Jeffrey S

Volltext

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma von SAMPSON, John H, HEIMBERGER, Amy B, REARDON, David A, SAWAYA, Raymond, SCHMITTLING, Robert J, WEIMING SHI, VREDENBURGH, James J, BIGNER, Darell D, ARCHER, Gary E, ALDAPE, Kenneth D, FRIEDMAN, Allan H, FRIEDMAN, Henry S, GILBERT, Mark R, HERNDON, James E, MCLENDON, Roger E, MITCHELL, Duane A

Volltext

Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments von Ozcan, Gonca, Singh, Meghana, Vredenburgh, James J

Volltext

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme von VREDENBURGH, James J, DESJARDINS, Annick, WAGNER, Melissa, BAILEY, Leighann, BIGNER, Darell D, FRIEDMAN, Allan H, FRIEDMAN, Henry S, HERNDON, James E, MARCELLO, Jennifer, REARDON, David A, QUINN, Jennifer A, RICH, Jeremy N, SATHORNSUMETEE, Sith, GURURANGAN, Sridharan, SAMPSON, John

Volltext

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients von Reardon, D A, Herndon, J E, Peters, K B, Desjardins, A, Coan, A, Lou, E, Sumrall, A L, Turner, S, Lipp, E S, Sathornsumetee, S, Rich, J N, Sampson, J H, Friedman, A H, Boulton, S T, Bigner, D D, Friedman, H S, Vredenburgh, J J

Volltext

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma von VREDENBURGH, James J, DESJARDINS, Annick, BIGNER, Darell D, FRIEDMAN, Allan H, FRIEDMAN, Henry S, HERNDON, James E, DOWELL, Jeannette M, REARDON, David A, QUINN, Jennifer A, RICH, Jeremy N, SATHORNSUMETEE, Sith, GURURANGAN, Sridharan, WAGNER, Melissa

Volltext

Repeatability of Automated Image Segmentation with BraTumIA in Patients with Recurrent Glioblastoma von Abu Khalaf, N, Desjardins, A, Vredenburgh, J J, Barboriak, D P

Volltext

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study von Reardon, D A, Desjardins, A, Vredenburgh, J J, Gururangan, S, Sampson, J H, Sathornsumetee, S, McLendon, R E, Herndon, J E, Marcello, J E, Norfleet, J, Friedman, A H, Bigner, D D, Friedman, H S

Volltext

Bevacizumab and daily temozolomide for recurrent glioblastoma von Desjardins, Annick, Reardon, David A., Coan, April, Marcello, Jennifer, Herndon, James E., Bailey, Leighann, Peters, Katherine B., Friedman, Henry S., Vredenburgh, James J.

Volltext

Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study von Yung, W.K. Alfred, Vredenburgh, James J., Cloughesy, Timothy F., Nghiemphu, Phioanh, Klencke, Barbara, Gilbert, Mark R., Reardon, David A., Prados, Michael D.

Volltext

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma von Sampson, John H., Aldape, Kenneth D., Archer, Gary E., Coan, April, Desjardins, Annick, Friedman, Allan H., Friedman, Henry S., Gilbert, Mark R., Herndon, James E., McLendon, Roger E., Mitchell, Duane A., Reardon, David A., Sawaya, Raymond, Schmittling, Robert, Shi, Weiming, Vredenburgh, James J., Bigner, Darell D., Heimberger, Amy B.

Volltext

Molecularly targeted therapy for malignant glioma von Sathornsumetee, Sith, Reardon, David A., Desjardins, Annick, Quinn, Jennifer A., Vredenburgh, James J., Rich, Jeremy N.

Volltext

Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas von Cuneo, Kyle C., M.D, Vredenburgh, James J., M.D, Sampson, John H., M.D., Ph.D, Reardon, David A., M.D, Desjardins, Annick, M.D, Peters, Katherine B., M.D., Ph.D, Friedman, Henry S., M.D, Willett, Christopher G., M.D, Kirkpatrick, John P., M.D., Ph.D

Volltext

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma von Sampson, John H, Schmittling, Robert J, Archer, Gary E, Congdon, Kendra L, Nair, Smita K, Reap, Elizabeth A, Desjardins, Annick, Friedman, Allan H, Friedman, Henry S, Herndon, 2nd, James E, Coan, April, McLendon, Roger E, Reardon, David A, Vredenburgh, James J, Bigner, Darell D, Mitchell, Duane A

Volltext

The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma von VREDENBURGH, James J, DESJARDINS, Annick, FRIEDMAN, Allan H, BIGNER, Darell D, FRIEDMAN, Henry S, REARDON, David A, PETERS, Katherine B, HERNDON, James E, MARCELLO, Jennifer, KIRKPATRICK, John P, SAMPSON, John H, BAILEY, Leighann, THREATT, Stevie

Volltext

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan von SATHORNSUMETEE, Sith, YITING CAO, MARCELLO, Jennifer E, HERNDON, James E, MCLENDON, Roger E, DESJARDINS, Annick, FRIEDMAN, Henry S, DEWHIRST, Mark W, VREDENBURGH, James J, RICH, Jeremy N

Volltext

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma von Reardon, David A., Desjardins, Annick, Peters, Katherine B., Gururangan, Sridharan, Sampson, John H., McLendon, Roger E., Herndon, James E., Bulusu, Anuradha, Threatt, Stevie, Friedman, Allan H., Vredenburgh, James J., Friedman, Henry S.

Volltext

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas von DESJARDINS, Annick, REARDON, David A, SIGNER, Darell D, FRIEDMAN, Allan H, FRIEDMAN, Henry S, VREDENBURGH, James J, HERNDON, James E, MARCELLO, Jennifer, QUINN, Jennifer A, RICH, Jeremy N, SATHORNSUMETEE, Sith, GURURANGAN, Sridharan, SAMPSON, John, BAILEY, Leighann

Volltext

Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma von RUDEN, Emily, REARDON, David A, FRIEDMAN, Allan H, FRIEDMAN, Henry S, PETERS, Katherine B, JONES, Lee W, COAN, April D, HERNDON, James E, HORNSBY, Whitney E, WEST, Miranda, FELS, Diane R, DESJARDINS, Annick, VREDENBURGH, James J, WANER, Emily

Volltext

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma von Mathew Thomas, Vinay, Bindal, Poorva, Vredenburgh, James J.

Volltext